Milestone Scientific (MLSS) 3.40 $MLSS
Milestone wins USD4.2m StemInject Project grant for treatment of diabetes
M2 - Fri Jul 03, 5:41AM CDT
Medical company Milestone Scientific (NYSE MKT:MLSS) reported on Thursday that it has received a USD4.2m grant for research and development in Poland under its STRATEGMED Programme to develop and commercialise a novel injection instrument for delivering stem cells and other medications to treat diabetes (StemInject Project).
MLSS: 3.40 (+0.11)
Milestone Led Consortium Awarded $4.2 Million to Develop Stem Cell Medium and Instrument for Treatment of Diabetes
Marketwired - Thu Jul 02, 7:30AM CDT
Milestone Scientific Inc. (NYSE MKT: MLSS) today announced that a consortium led by Milestone Scientific Poland Sp. z.o.o., a subsidiary of Milestone Scientific Inc., had been awarded a $4.2 Million grant by the National Centre for Research and Development in Poland under its STRATEGMED Program to develop and commercialize a novel injection instrument for delivering stem cells and other medications to treat diabetes ("StemInject Project"
. The instrument will be based on Milestone Scientific's painless, computer-controlled injection and drug delivery technology, which has commercial applications across a broad spectrum of medical and dental procedures. Milestone Scientific Poland will receive approximately $1.5M of this grant.
MLSS: 3.40 (+0.11)
Milestone Scientific announces first shipments of Epidural Instrument in Europe
M2 - Wed Jul 01, 5:53AM CDT
Medical R&D company Milestone Scientific (NYSE MKT:MLSS) revealed on Tuesday that it has started the first shipments of its CompuFlo Epidural Instrument to distributors and key opinion leaders in Europe through its Epidural & Intra-Articular (IA) subsidiary.
MLSS: 3.40 (+0.11)
Milestone Scientific's Epidural & IA Subsidiary Commences First Shipments of Epidural Instrument in Europe
Marketwired - Tue Jun 30, 6:30AM CDT
Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has commenced the first shipments of its CompuFlo(TM) Epidural Instrument to distributors and key opinion leaders in Europe.
MLSS: 3.40 (+0.11)
Milestone Scientific's Epidural & IA Subsidiary and Moss S.p.A. Sign Exclusive Distribution Agreement for Epidural Instrument in Italy
Marketwired - Wed Jun 10, 6:30AM CDT
Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has entered into an exclusive distribution agreement with Moss S.p.A. for distribution of the epidural instrument in Italy. Moss is one of the leading distributors of diagnostic and specialty surgery equipment in Italy.
MLSS: 3.40 (+0.11)
Milestone Scientific to trade on the NYSE MKT today and other NLSP Market Insights
M2 - Mon Jun 01, 2:39AM CDT
Companies mentioned in this article: Milestone Scientific Inc. (MLSS), Source Financial Inc. (SRCF), Avago (AVGO), Broadcom (BRCM), Intel (INTC) and Altera (ALTR).
BRCM: 52.06 (+1.41), ALTR: 49.75 (+0.29), INTC: 29.17 (+0.24), MLSS: 3.40 (+0.11), AVGO: 129.84 (+5.16)
Milestone Scientific to Uplist to the NYSE MKT and NLSP Market Insights
M2 - Fri May 29, 8:03AM CDT
Companies mentioned in this article: Milestone Scientific Inc. (MLSS), Source Financial Inc. (SRCF), One Horizon Group Inc. (NASDAQ: OHGI), Axion Power International, Inc. (NASDAQ:AXPW), and Opexa Therapeutics Inc. (NASDAQ:OPXA).
OPXA: 0.44 (-0.01), AXPW: 0.09 (+0.01), MLSS: 3.40 (+0.11), OHGI: 2.70 (+0.08)
Milestone Scientific to list at the NYSE MKT to reflect its continued progress in medical instruments technology
M2 - Fri May 29, 7:26AM CDT
Medical R&D company Milestone Scientific (Other OTC:MLSS) disclosed on Thursday that its common stock have been approved for listing on the NYSE MKT.
MLSS: 3.40 (+0.11)
Milestone Scientific Announces Approval for Listing on the NYSE MKT
Marketwired - Thu May 28, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its shares of common stock have been approved for listing on the NYSE MKT, subject to continued satisfaction of listing requirements. Trading on the NYSE MKT is expected to commence on June 1, 2015. The Company will continue to trade under the symbol "MLSS."
MLSS: 3.40 (+0.11)
Milestone Scientific's Epidural & IA Subsidiary and Fidia Farmaceutici SpA Sign MOU for Co-Development and Manufacture of Custom Intra-Articular Drug Delivery Instrument
Marketwired - Wed May 27, 6:32AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has signed a Memorandum of Understanding (MOU) with Fidia Farmaceutici SpA, a specialty pharmaceutical company based in Italy, for the co-development and manufacture of a custom intra-articular drug delivery instrument for Fidia's hyaluronic acid formulations. Fidia is a leading producer of hyaluronic acid formulations for joint pain.
MLSS: 3.40 (+0.11)
Milestone Scientific to Present at the SeeThruEquity 4th Annual Microcap Investor Conference in New York
Marketwired - Fri May 22, 9:11AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Leonard Osser, CEO of Milestone Scientific, will present at the SeeThruEquity 4th Annual Microcap Investor Conference at 3:30 p.m. Eastern Daylight Savings Time on May 28, 2015 at Convene Grand Central in New York City.
MLSS: 3.40 (+0.11)
Milestone Scientific to Present at the Marcum MicroCap Conference
Marketwired - Thu May 21, 7:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Leonard Osser, CEO of Milestone Scientific, will present on Wednesday, May 27, 2015 at 3:30 p.m. Eastern Time at the Marcum MicroCap Conference to be held at the Grand Hyatt New York from May 27 - 28, 2015.
MLSS: 3.40 (+0.11)
Milestone Scientific Reports First Quarter 2015 Financial Results and Provides Business Update
Marketwired - Thu May 14, 6:02PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the first quarter ended March 31, 2015 and provided a business update including its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary".
MLSS: 3.40 (+0.11)
Milestone wins USD4.2m StemInject Project grant for treatment of diabetes
M2 - Fri Jul 03, 5:41AM CDT
Medical company Milestone Scientific (NYSE MKT:MLSS) reported on Thursday that it has received a USD4.2m grant for research and development in Poland under its STRATEGMED Programme to develop and commercialise a novel injection instrument for delivering stem cells and other medications to treat diabetes (StemInject Project).
MLSS: 3.40 (+0.11)
Milestone Led Consortium Awarded $4.2 Million to Develop Stem Cell Medium and Instrument for Treatment of Diabetes
Marketwired - Thu Jul 02, 7:30AM CDT
Milestone Scientific Inc. (NYSE MKT: MLSS) today announced that a consortium led by Milestone Scientific Poland Sp. z.o.o., a subsidiary of Milestone Scientific Inc., had been awarded a $4.2 Million grant by the National Centre for Research and Development in Poland under its STRATEGMED Program to develop and commercialize a novel injection instrument for delivering stem cells and other medications to treat diabetes ("StemInject Project"
. The instrument will be based on Milestone Scientific's painless, computer-controlled injection and drug delivery technology, which has commercial applications across a broad spectrum of medical and dental procedures. Milestone Scientific Poland will receive approximately $1.5M of this grant. MLSS: 3.40 (+0.11)
Milestone Scientific announces first shipments of Epidural Instrument in Europe
M2 - Wed Jul 01, 5:53AM CDT
Medical R&D company Milestone Scientific (NYSE MKT:MLSS) revealed on Tuesday that it has started the first shipments of its CompuFlo Epidural Instrument to distributors and key opinion leaders in Europe through its Epidural & Intra-Articular (IA) subsidiary.
MLSS: 3.40 (+0.11)
Milestone Scientific's Epidural & IA Subsidiary Commences First Shipments of Epidural Instrument in Europe
Marketwired - Tue Jun 30, 6:30AM CDT
Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has commenced the first shipments of its CompuFlo(TM) Epidural Instrument to distributors and key opinion leaders in Europe.
MLSS: 3.40 (+0.11)
Milestone Scientific's Epidural & IA Subsidiary and Moss S.p.A. Sign Exclusive Distribution Agreement for Epidural Instrument in Italy
Marketwired - Wed Jun 10, 6:30AM CDT
Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has entered into an exclusive distribution agreement with Moss S.p.A. for distribution of the epidural instrument in Italy. Moss is one of the leading distributors of diagnostic and specialty surgery equipment in Italy.
MLSS: 3.40 (+0.11)
Milestone Scientific to trade on the NYSE MKT today and other NLSP Market Insights
M2 - Mon Jun 01, 2:39AM CDT
Companies mentioned in this article: Milestone Scientific Inc. (MLSS), Source Financial Inc. (SRCF), Avago (AVGO), Broadcom (BRCM), Intel (INTC) and Altera (ALTR).
BRCM: 52.06 (+1.41), ALTR: 49.75 (+0.29), INTC: 29.17 (+0.24), MLSS: 3.40 (+0.11), AVGO: 129.84 (+5.16)
Milestone Scientific to Uplist to the NYSE MKT and NLSP Market Insights
M2 - Fri May 29, 8:03AM CDT
Companies mentioned in this article: Milestone Scientific Inc. (MLSS), Source Financial Inc. (SRCF), One Horizon Group Inc. (NASDAQ: OHGI), Axion Power International, Inc. (NASDAQ:AXPW), and Opexa Therapeutics Inc. (NASDAQ:OPXA).
OPXA: 0.44 (-0.01), AXPW: 0.09 (+0.01), MLSS: 3.40 (+0.11), OHGI: 2.70 (+0.08)
Milestone Scientific to list at the NYSE MKT to reflect its continued progress in medical instruments technology
M2 - Fri May 29, 7:26AM CDT
Medical R&D company Milestone Scientific (Other OTC:MLSS) disclosed on Thursday that its common stock have been approved for listing on the NYSE MKT.
MLSS: 3.40 (+0.11)
Milestone Scientific Announces Approval for Listing on the NYSE MKT
Marketwired - Thu May 28, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its shares of common stock have been approved for listing on the NYSE MKT, subject to continued satisfaction of listing requirements. Trading on the NYSE MKT is expected to commence on June 1, 2015. The Company will continue to trade under the symbol "MLSS."
MLSS: 3.40 (+0.11)
Milestone Scientific's Epidural & IA Subsidiary and Fidia Farmaceutici SpA Sign MOU for Co-Development and Manufacture of Custom Intra-Articular Drug Delivery Instrument
Marketwired - Wed May 27, 6:32AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has signed a Memorandum of Understanding (MOU) with Fidia Farmaceutici SpA, a specialty pharmaceutical company based in Italy, for the co-development and manufacture of a custom intra-articular drug delivery instrument for Fidia's hyaluronic acid formulations. Fidia is a leading producer of hyaluronic acid formulations for joint pain.
MLSS: 3.40 (+0.11)
Milestone Scientific to Present at the SeeThruEquity 4th Annual Microcap Investor Conference in New York
Marketwired - Fri May 22, 9:11AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Leonard Osser, CEO of Milestone Scientific, will present at the SeeThruEquity 4th Annual Microcap Investor Conference at 3:30 p.m. Eastern Daylight Savings Time on May 28, 2015 at Convene Grand Central in New York City.
MLSS: 3.40 (+0.11)
Milestone Scientific to Present at the Marcum MicroCap Conference
Marketwired - Thu May 21, 7:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Leonard Osser, CEO of Milestone Scientific, will present on Wednesday, May 27, 2015 at 3:30 p.m. Eastern Time at the Marcum MicroCap Conference to be held at the Grand Hyatt New York from May 27 - 28, 2015.
MLSS: 3.40 (+0.11)
Milestone Scientific Reports First Quarter 2015 Financial Results and Provides Business Update
Marketwired - Thu May 14, 6:02PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the first quarter ended March 31, 2015 and provided a business update including its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary"
. MLSS: 3.40 (+0.11)
